Clinical Trial Update: Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing topical imiquimod with surgery for basal cell carcinoma has completed; results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Imiquimod (imiquimod)

Snippet

Sponsor: Queen's Medical Center | Conditions: Non-melanomatous Skin Cancer | Phase 3 | Status: COMPLETED